Medical calculator

BARD Score for NAFLD Advanced Fibrosis

The BARD score was originally developed and validated by Harrison et al. (Gut 2008; 57(10): 1441–1446) as a simple clinical scoring system designed to identify patients with non-alcoholic fatty liver disease (NAFLD / MASLD) who do not have advanced hepatic fibrosis (F3 bridging fibrosis or F4 cirrhosis).

Clinical & Laboratory Parameters

Enter body mass index (BMI), routine transaminases (AST, ALT), and type 2 diabetes status

Body Mass Index (BMI)

Weight in kg divided by height in meters squared; >= 28.0 kg/m² scores 1 point, < 28.0 scores 0 points

kg/m²

Aspartate Aminotransferase (AST)

Serum AST concentration (U/L), used to compute the AST/ALT ratio

U/L

Alanine Aminotransferase (ALT)

Serum ALT concentration (U/L), used to compute the AST/ALT ratio (ratio >= 0.80 scores 2 points)

U/L

Type 2 Diabetes Mellitus

Established diagnosis of type 2 diabetes scores 1 point, absence scores 0 points

Please complete all required fields first.